Company Email Format Management

Galecto, Inc.

Biotechnology Research Copenhagen, Dk 17 employees

Employees: 17
Contacts: 4
Emails: 4

www.galecto.com LinkedIn Crunchbase

Galecto, Inc. Overview

Headquarters: Copenhagen, Dk
Website: www.galecto.com
Industry: Biotechnology Research
Employees: 17
Founded: 2011
Funding: 64.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Galectin modulators Galectin-3 inhibitors Fibrosis treatment LOXL2 Inflammation Oncology IPF Liver fibrosis Myelofibrosis

About Galecto, Inc.

Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure and SEED Capital.

Galecto, Inc. Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage

Galecto, Inc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Becky Smith		London, England, United Kingdom	Email
Hans T. Schambye	President & CEO at Galecto, Inc.	Copenhagen, Capital Region of Denmark, Denmark	Email
Jayson Dallas		San Francisco Bay Area, United States	Email
Amit Munshi		Park City, Utah, United States	Email